JOURNAL OF PRACTICAL HEPATOLOGY ›› 2012, Vol. 15 ›› Issue (2): 81-83.doi: 10.3969/j.issn.1672-5069.2012.02.001
Received:
2011-12-13
Online:
2012-04-10
Published:
2017-03-07
[1] Williams CD,Stengel J,Asike MI,et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy:a prospective study. Gastroenterology,2011,140:124-131. [2] Wong VW,Chu WC,Wong GL,et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese:a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut,2011,[Epub ahead of print]. [3] Wong VW,Wong GL,Chu WC,et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol,2011, [Epub ahead of print] [4] Ayonrinde OT,Olynyk JK,Beilin LJ,et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology,2011,53:800-809. [5] Santoro N,Zhang CK,Zhao H,et al. A variant in the glucokinase regulatory protein(GCKR)gene is associated with fatty liver in obese children and adolescents. Hepatology,2011,[Epub ahead of print] [6] Lomonaco R,Ortiz-Lopez C,Orsak B,et al. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology,2011,[Epub ahead of print] [7] Bambha K,Belt P,Abraham M,et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology,2011,[Epub ahead of print] [8] Sookoian S,Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology,2011,53:1883-1894. [9] Al-Serri A,Anstee QM,Valenti L,et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity:Evidence from case-control and intra-familial allele association studies. J Hepatol,2011. [Epub ahead of print] [10] Molloy JW,Calcagno CJ,Williams CD,et al. Association of coffee and caffeine consumption with fatty liver disease,non-alcoholic steatohepatitis,and degree of hepatic fibrosis. Hepatology,2011,[Epub ahead of print] [11] Aron-Wisnewsky J,Minville C,Tordjman J,et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol,2011,[Epub ahead of print] [12] Lemoine M,Serfaty L. Chronic intermittent hypoxia:A breath of fresh air in the understanding of NAFLD pathogenesis. J Hepatol,2011,[Epub ahead of print]. [13] Nelson JE,Wilson L,Brunt EM,et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology,2011,53:448-457. [14] Charlton MR,Burns JM,Pedersen RA,et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology,2011,141:1249-1253. [15] Younossi ZM,Stepanova M,Rafiq N,et al. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality. Hepatology,2011,53:1874-1882. [16] Wong VW,Wong GL,Tsang SW,et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut,2011,60:829-836. [17] Palmeri ML,Wang MH,Rouze NC,et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol,2011,55:666-672. [18] Pihlajamaki J,Kuulasmaa T,Kaminska D,et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol,2011,[Epub ahead of print] [19] Joka D,Wahl K,Moeller S,et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology,2011,[Epub ahead of print] [20] Sanyal AJ,Brunt EM,Kleiner DE,et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology,2011,54:344-353. |
[1] | Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764. |
[2] | National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792. |
[3] | . Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803. |
[4] | Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807. |
[5] | Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851. |
[6] | Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855. |
[7] | Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899. |
[8] | Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903. |
[9] | Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937. |
[10] | Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943. |
[11] | Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655. |
[12] | Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663. |
[13] | Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675. |
[14] | Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699. |
[15] | Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||